Peanut Allergy Treatment Market to Grow with a CAGR of 12.84% through 2030
Increasing Prevalence of Peanut Allergy is expected to drive the growth of Global Peanut Allergy Treatment Market in the forecast period, 2026-2030.
According to TechSci Research report, “Peanut
Allergy Treatment Market –Industry Size, Share, Trends, Opportunity, and
Forecast, 2030F”, Peanut Allergy Treatment Market stood at USD 586.10 million in 2024 and is anticipated to grow with a CAGR of 12.84% in the forecast period through 2030. This can be ascribed in the forecasted years
due to the increasing prevalence of peanut allergy,
improved understanding of peanut allergy, advances in technology and increased
investment in research and development.
The Global
Peanut Allergy Treatment Market is influenced by several factors, including the
increasing prevalence of peanut allergies, which has resulted in growing demand
for effective treatments. Additionally, the growing awareness of peanut
allergies, advancements in technology, and increasing investment in research
and development activities have led to the development of new and innovative
treatments for peanut allergies. The availability of various treatment options,
government initiatives and regulations, and the rising adoption of telemedicine
and remote consultations have played a role in driving the growth of the
market. As these factors continue to evolve, the Global Peanut Allergy
Treatment Market is expected to grow and expand further in the coming years.
The Global
Peanut Allergy Treatment Market faces various challenges that impede its
growth, including the high cost of peanut allergy treatments and the lack of
affordability for many patients. Additionally, the high development costs
associated with developing new treatments can be a barrier to entry for smaller
companies, limiting innovation in the market. The potential side effects and
risks associated with some treatments can lead to a lack of patient compliance
and reduced efficacy. The lack of standardized diagnostic tools and the limited
understanding of the underlying mechanisms of peanut allergies further
complicate the development of effective treatments.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global
Peanut Allergy Treatment Market"
Global Peanut Allergy Treatment Market can be
segmented by drug class, route of administration, distribution channel, regional distribution and company.
Based on the route of administration, the oral category is showing the fastest growth in the global peanut allergy treatment market. This surge in adoption is largely driven by advancements in oral immunotherapy (OIT), a method that involves the gradual introduction of small amounts of peanut protein to help build tolerance in allergic individuals. Oral treatments offer a non-invasive, more manageable approach for long-term desensitization and are gaining popularity among healthcare providers and patients alike. The convenience and ease of oral administration contribute significantly to its rising preference. Unlike injectable treatments, oral therapies can often be administered at home under guided supervision after the initial phase in a clinical setting. This reduces the need for frequent hospital visits, making it especially appealing for pediatric cases and for patients in rural or underserved areas with limited access to specialist allergy care.
Based on Region, Asia Pacific is emerging as the fastest-growing region in the global peanut allergy treatment market, driven by a combination of demographic, economic, and healthcare system developments. One of the key factors contributing to this rapid growth is the increasing awareness of food allergies, particularly in urban areas where dietary patterns are shifting and exposure to allergens like peanuts is becoming more common. As globalization introduces more Western food products into the diets of many Asian populations, the incidence of food-related allergies, including peanut allergies, has been gradually rising. Alongside this trend, countries in the Asia Pacific region are investing heavily in improving their healthcare infrastructure and diagnostic capabilities. Governments in countries like China, India, Japan, South Korea, and Australia are prioritizing public health initiatives, including early allergy diagnosis and awareness campaigns. These efforts are fostering greater understanding and detection of peanut allergies, which in turn is driving demand for more advanced treatment options.
Major companies operating in Global Peanut Allergy Treatment Market
are:
- Vedanta Biosciences, Inc.
- Alladapt Immunotherapeutics, Inc.
- Regeneron Pharmaceuticals Inc.
- Aravax Pty Ltd
- Teva Pharmaceutical Industries Limited
- Prota Therapeutics Pty Ltd.
- Aimmune Therapeutics, Inc. (Nestle)
- DBV Technologies SA
- Sanofi SA
- Mylan N.V.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“Due to the rising incidence of peanut
allergies and desire for efficient treatments, the global market for peanut
allergy treatments is expanding significantly. Antihistamines, epinephrine,
immunotherapy, and other therapeutic alternatives are readily available in the
market. New and creative therapies for peanut allergies have been created as a
result of the increased public knowledge of peanut allergies, and technological
developments. Government policies, legislation, and the growing use of
telemedicine and remote consultations have an impact on the industry. However,
the market many challenges, such as the high cost of therapies, difficulties
with the regulatory system, and potential side effects connected with
particular treatments.” said Mr. Karan Chechi, Research Director of TechSci
Research, a research based global management consulting firm.
“Peanut Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Antihistamines, Epinephrine, Immunotherapies, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Peanut Allergy Treatment Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Peanut Allergy Treatment Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com